Safety Rates Drug Report: ELOXATIN Peripheral swelling adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: ELOXATIN Injury: Peripheral swelling Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 2 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
126934361	ELOXATIN	Peripheral swelling		57.64 YR	M	122 KG	20160826	US
127237101	ELOXATIN	Peripheral swelling	FDA-CTU	57.64 YR	M	122 KG	20160902	US

|< 1/2 << Previous Page Page 1

Total Records: 2 Number of Pages: 1

Execution Time: 0.0080931186676025 seconds (ucode:5183443). Developed by: James D. Barger